Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation.
Bone Marrow Transplant. 2021 Nov;56(11):2804-2812. doi: 10.1038/s41409-021-01416-5. Epub 2021 Jul 17.
Bone Marrow Transplant. 2021.
PMID: 34274954
Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients.
Zucenka A, Maneikis K, Pugaciute B, Ringeleviciute U, Dapkeviciute A, Davainis L, Daukelaite G, Burzdikaite P, Staras V, Griskevicius L.
Zucenka A, et al. Among authors: staras v.
Ann Hematol. 2021 May;100(5):1195-1202. doi: 10.1007/s00277-021-04471-6. Epub 2021 Mar 4.
Ann Hematol. 2021.
PMID: 33661333
Free PMC article.
Item in Clipboard
Cite
Cite